b2venture logo

b2venture

Europe, Berlin, Germany, Berlin

Description

b2venture, formerly known as btov Partners, is a distinguished European venture capital firm headquartered in Berlin, Germany, with additional offices across Europe. The firm focuses on early-stage investments, primarily targeting digital and industrial technology companies. A cornerstone of b2venture's unique investment model is its extensive network of over 250 private investors, known as "Partner Investors," who co-invest alongside the firm's institutional funds. This hybrid approach not only amplifies capital deployment but also provides portfolio companies with invaluable access to a diverse pool of entrepreneurial expertise and industry connections.

b2venture strategically invests across various sectors within the technology landscape, demonstrating a particular interest in B2B software, fintech, healthtech, and deep tech innovations. They engage with companies from Seed to Series B stages, providing crucial capital and strategic guidance during formative growth periods. Their investment philosophy emphasizes long-term partnerships, supporting founders beyond the initial capital injection through follow-on rounds and network leverage.

The firm manages significant capital, with its b2venture Fund IV successfully closing at over €100 million (approximately $108 million) in 2023, underscoring its capacity for substantial early-stage commitments. For initial investments, b2venture typically writes first checks ranging from €500,000 to €5 million (approximately $540,000 to $5.4 million). They also have the capacity for significant follow-on investments, potentially committing up to €20 million per company throughout its lifecycle. This flexible and robust funding strategy positions b2venture as a key player in the European venture capital ecosystem, dedicated to fostering the next generation of technology leaders.

Investor Profile

b2venture has backed more than 227 startups, with 14 new investments in the last 12 months alone. The firm has led 46 rounds, about 20% of its total and boasts 34 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in Germany, Switzerland, United Kingdom.
  • Strong thematic focus on Software, Health Care, Information Technology.
  • Led 3 rounds in the past year.
  • Typical check size: $540K – $5.4M.

Stage Focus

  • Series A (28%)
  • Seed (21%)
  • Series B (18%)
  • Series Unknown (13%)
  • Pre Seed (7%)
  • Series C (7%)
  • Series D (3%)
  • Series E (1%)
  • Angel (1%)

Country Focus

  • Germany (57%)
  • Switzerland (17%)
  • United Kingdom (7%)
  • United States (4%)
  • Israel (4%)
  • Spain (2%)
  • France (2%)
  • The Netherlands (2%)
  • Austria (1%)
  • Italy (1%)

Industry Focus

  • Software
  • Health Care
  • Information Technology
  • Artificial Intelligence (Ai)
  • Medical
  • Financial Services
  • Internet
  • Fintech
  • Biotechnology
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does b2venture frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 9
Matterwave Ventures
Europe, Bayern, Germany, Munich
Co-Investments: 9
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 10
DN Capital
North America, California, United States, Menlo Park
Co-Investments: 8
Ringier Digital Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 10
EA
Europe, Berlin, Germany, Berlin
Co-Investments: 8
RD
Europe, Berlin, Germany, Berlin
Co-Investments: 8
TA Ventures
Europe, Hessen, Germany, Frankfurt
Co-Investments: 8
HV Capital
Europe, Bayern, Germany, Munich
Co-Investments: 17
UVC Partners
Europe, Bayern, Germany, Garching
Co-Investments: 9

Which angels does b2venture often collaborate with?

MH
Europe, Berlin, Germany, Berlin
Shared Deals: 4
MV
Europe, Berlin, Germany, Berlin
Shared Deals: 3
AL
Europe, Zurich, Switzerland, Zurich
Shared Deals: 2
DG
Europe, Zurich, Switzerland, Zürich
Shared Deals: 3
HH
Europe, Bayern, Germany, Munich
Shared Deals: 2
NO
Europe, Zurich, Switzerland
Shared Deals: 2
SA
Europe, Istanbul, Turkey, Istanbul
Shared Deals: 3
PS
Europe, Zurich, Switzerland, Zürich
Shared Deals: 2
JB
Europe, Berlin, Germany, Berlin
Shared Deals: 2
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by b2venture?

Nautica Technologies

Zürich, Zurich, Switzerland

Nautica Technologies is developing intelligent robotic technologies for autonomous ship hull cleaning and inspection.

Robotics
SeedJul 3, 2025
Amount Raised: $4,000,000
Kiin Bio

London, England, United Kingdom

Kiin Bio operates as an AI-native platform that unifies drug discovery tools.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
Pre SeedJun 5, 2025
Amount Raised: $2,172,676
VESTIGAS

Eggenfelden, Bayern, Germany

VESTIGAS is the new standard for Purchase-to-Pay Interactions in Construction.

ConstructionLogisticsSoftware
SeedApr 9, 2025
Amount Raised: $8,761,382
Miss Moneypenny Technologies

Berlin, Berlin, Germany

Miss Moneypenny Technologies offers a journey-builder for wallet passes in native digital wallet apps (Apple Wallet and Google Pay)

Information ServicesInformation Technology
SeedApr 7, 2025
Amount Raised: $8,016,666
Vantis

Munich, Bayern, Germany

Vantis is a digital solution for chronic cardiovascular diseases that requires personalized ongoing treatment for decades.

Health Care
Series AMar 12, 2025
Amount Raised: $10,911,539
assemblean

Paderborn, Nordrhein-Westfalen, Germany

assemblean goal is to construct the digital manufacturing infrastructure of the future.

PaaSSoftware
SeedFeb 4, 2025
Amount Raised: $1,859,823
Nelly

Berlin, Berlin, Germany

Nelly provides a tool for medical practices that simplifies patient onboarding and payments.

Financial ServicesHealth CareInsuranceMedicalPayments
Series BJan 14, 2025
Amount Raised: $51,537,997
NVision Imaging Technologies

Ulm, Baden-Wurttemberg, Germany

NVision Imaging Technologies develops Quantum MRI agents for assessing early patient response to treatment at the metabolic level.

BiopharmaBiotechnologyHealth DiagnosticsMedical DevicePharmaceutical
Series BDec 20, 2024
Amount Raised: $26,078,750
1Komma5°

Hamburg, Hamburg, Germany

1Komma5° is an electricity company offering free electricity to all electric vehicle owners financed through trading using GHG quotas.

ManufacturingRenewable EnergySemiconductor
Series UnknownDec 20, 2024
Amount Raised: $156,472,484
Predium

Munich, Bayern, Germany

The Real Estate Intelligence Platform for sustainable capital decisions

Information ServicesReal EstateSoftware
Series ANov 28, 2024
Amount Raised: $13,728,329